Psychiatric Practice Takes Another Blow—Psychotherapy is better for Major Depression


  The New York Times says the gas tax should be increased and that prosperity will follow. Raise taxws for prosperity? Modern Keynseianism. Never worked, but keeps being tried.

   154 Walmart stores to close. If only they paid higher wages, more stores would remain open. Oh wait, that’s not the way it works. Walmart, like all of us in the free market, has a large pile of money it hoards for the sake of hoarding and just will not share.—This is the kind of nonsense progressives spread. What will they say now? Working for low wages is worse than not working for high wages?

    Do not think about, write about or deal with  human behavior without determining the effects of incentives. It’s not their money, of course they’ll waste it.

    Wherein we see, once again, that psychiatric drugs are ineffective. For several decades the cant was that major depression could only be treated by antidepressive drugs. One of the last bastions of psychiatric  myth has fallen as seen below.

Therapy Effective and Efficient for Long-Term For Depression

There is robust evidence for the long-term effectiveness of psychotherapy, and it also provides good value-for-money, according to a large randomized control trial published open-access this month in The Lancet. The researchers recommend that clinicians refer all patients with treatment-resistant depression to therapy.

CoBalT aims to find out whether giving CBT in addition to antidepressants can improve outcomes for people with treatment resistant depression, compared to antidepressant treatment alone.

The researchers examined a particular style of therapy, Cognitive Behavioral Therapy (CBT), which past research has shown to be a particularly effective treatment for depression. They explain that CBT “teaches patients skills to help them better manage their mood, and so has the potential to result in a benefit that is sustained beyond the end of therapy.” While CBT has been tested and found effective for depression, including treatment-resistant depression, few studies have tracked the long-term results of this approach.

Treatment-resistant depression (TRD), which is also referred to as "refractory depression," "chronic depression," and "difficult-to-treat depression,"  is commonly defined by the failure to respond to two different antidepressants. However, the past research indicates that approximately 60% of patients do not respond to antidepressants and that, therefore, "treatment-resistance" might be better characterized as a diagnostic “paradigm failure."

Current treatment guidelines suggest that antidepressants be used over psychotherapy for major depressive disorder. An analysis published in JAMA in September, however, found that “patients with more severe depression were no more likely to require medications to improve than patients with less severe depression.” The same study also suggested that CBT may be used an effective first-line treatment for severely depressed patients.

The current study is based on the long-term follow-up data from the CoBalT trial, a pragmatic, multicentre randomized control trial across seventy-three treatment centers in the UK that investigated cognitive-behavioral therapy as an adjunct therapy to antidepressants for treatment-resistant depression. The CoBalT trial study authors estimate that "two-thirds of people with depression don’t respond fully to antidepressants, even after an adequate dose and duration of treatment."

The study aimed “to examine whether CBT (in addition to usual care that included pharmacotherapy) was effective and cost efficient in reducing depressive symptoms and improving quality of life over the long-term (3–5 years) compared with usual care alone in primary care patients.”

After receiving 12-18 sessions of CBT the patients were asked to respond to a questionnaire by mail, assessing their depressive symptoms over the next three to five years. After controlling for demographic differences and other potential confounders, the researchers found that participants who received therapy had significantly less depressive symptoms at follow-up.

    “Individuals in the intervention group had nearly a three-fold increased odds of response over the 46 months compared with those in the usual care group,” the researchers write.

Those who received CBT were also more likely to experience remission, report reduced anxiety, and show greater improvement in overall mental health. Also, those who received therapy were less likely to be taking antidepressants at 46 weeks.

To evaluate the cost-effectiveness of CBT, the researchers obtained health care resource records and estimated participants use of health care services over the follow-up period. It was estimated that the averages cost per patient for the CBT intervention was £343, but that health and social services costs were higher in the usual care group over the long-term.

    “CBT as an adjunct to usual care was an effective treatment for primary care patients with treatment-resistant depression over the long-term, and represented good value for money,” the researchers concluded. “Clinicians need to discuss referral for CBT with all those for whom antidepressants are not effective.”

Wiles, N. J., Thomas, L., Turner, N., Garfield, K., Kounali, D., Campbell, J., … & Williams, C. (2016). Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial. The Lancet Psychiatry. (Full text)


   These results are interesting, but psychiatric research in general must use better methods to assess treatment effectiveness such as days worked, amount slept, exercise, weight and many others.

Government Job or Respect–Which’ll It Be?
Cheerio and ttfn,
Grant Coulson, Ph.D.
Author, “Power Teaching: How to Find Someone to Teach Your Child when the Education System has Failed.
Cui Bono–Cherchez les Contingencies



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: